The Municipal Corporation of Delhi (MCD) is set to procure 98,500 vials of anti-rabies vaccine to meet requirements over the next two years and ensure timely treatment for victims of animal bites at its hospitals and health centres.
“Providing timely treatment to victims of animal attacks is a priority for the corporation. MCD’s hospital administration department is undertaking the procurement at an estimated cost of ₹ 2.52 crore under a two-year rate contract for 1ml anti-rabies vaccine vials.
With this objective, the MCD has assessed the requirements of its healthcare services and prepared a procurement plan to meet the vaccine requirements for the next two years,” said Sharma.
The procurement of 98,500 vials, approved on Monday, is part of the MCD’s plan to acquire 1.20 lakh anti-rabies vaccine vials over the next two years, with 21,500 vials already purchased in May 2026. The move is expected to benefit thousands of residents, particularly in low-income neighbourhoods, who rely on MCD-run facilities for post-exposure treatment following dog bites.
